The experimental coronavirus treatment remdesivir has generated “positive data” in a trial of the antiviral organized by the National Institute of Allergy and Infectious Diseases (NIAID), according to developer Gilead Sciences.
from FOX News https://ift.tt/2KNq8fa
v
Wednesday, 29 April 2020
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment